1. Home
  2. CHCO vs HRMY Comparison

CHCO vs HRMY Comparison

Compare CHCO & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo City Holding Company

CHCO

City Holding Company

HOLD

Current Price

$125.53

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$39.27

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHCO
HRMY
Founded
1957
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CHCO
HRMY
Price
$125.53
$39.27
Analyst Decision
Hold
Strong Buy
Analyst Count
3
9
Target Price
$128.33
$51.33
AVG Volume (30 Days)
89.3K
773.3K
Earning Date
01-22-2026
11-04-2025
Dividend Yield
2.77%
N/A
EPS Growth
11.27
50.44
EPS
8.68
3.17
Revenue
$307,880,000.00
$825,944,000.00
Revenue This Year
$10.45
$23.11
Revenue Next Year
$3.18
$16.15
P/E Ratio
$14.47
$12.40
Revenue Growth
6.33
21.13
52 Week Low
$102.22
$25.52
52 Week High
$133.59
$40.93

Technical Indicators

Market Signals
Indicator
CHCO
HRMY
Relative Strength Index (RSI) 64.51 76.12
Support Level $119.79 $32.77
Resistance Level $123.75 $40.00
Average True Range (ATR) 2.48 1.25
MACD 0.43 0.26
Stochastic Oscillator 90.89 86.38

Price Performance

Historical Comparison
CHCO
HRMY

About CHCO City Holding Company

City Holding Co is a financial holding company. The company conducts its principal activities through its wholly-owned subsidiary, City National Bank of West Virginia (City National). Through the bank, it provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, savings accounts, credit cards and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance products, and others. The company's business activities are currently limited to one reportable business segment, which is community banking.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: